123 related articles for article (PubMed ID: 2442211)
1. Mitochondrial ring-phenomenon of keratinocytes in psoriasis vulgaris after dithranol therapy.
Klug H; Schulze P
J Cutan Pathol; 1987 Aug; 14(4):212-6. PubMed ID: 2442211
[No Abstract] [Full Text] [Related]
2. Unusual mitochondrial reaction in psoriatic keratinocytes.
Klug H; Schulze P
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 56(3):201-3. PubMed ID: 2906191
[TBL] [Abstract][Full Text] [Related]
3. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
Yamamoto T; Nishioka K
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
[TBL] [Abstract][Full Text] [Related]
4. Cytokinetic effects of anthralin on psoriatic keratinocytes.
Pullmann H; Enderer K; Steigleder GK
Br J Dermatol; 1981 Aug; 105 Suppl 20():55-6. PubMed ID: 6169362
[No Abstract] [Full Text] [Related]
5. [Abnormal mitochondria--a specific phenomenon of psoriatic keratinocytes?].
Klug H; Schulze P; Sönnichsen N
Dermatol Monatsschr; 1988; 174(6):305-7. PubMed ID: 2463184
[No Abstract] [Full Text] [Related]
6. Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris.
Kemény L; Ruzicka T; Braun-Falco O
Skin Pharmacol; 1990; 3(1):1-20. PubMed ID: 2202336
[TBL] [Abstract][Full Text] [Related]
7. The effect of fumaric acid esters and dithranol on acanthosis and hyperproliferation in psoriasis vulgaris.
Bacharaçh-Buhles M; Röchling A; el Gammal S; Altmeyer P
Acta Derm Venereol; 1996 May; 76(3):190-3. PubMed ID: 8800297
[TBL] [Abstract][Full Text] [Related]
8. Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: a clinical and pathologic study.
Gottlieb SL; Heftler NS; Gilleaudeau P; Johnson R; Vallat VP; Wolfe J; Gottlieb AB; Krueger JG
J Am Acad Dermatol; 1995 Oct; 33(4):637-45. PubMed ID: 7545705
[TBL] [Abstract][Full Text] [Related]
9. [Urea in combination with dithranol in treating psoriasis vulgaris].
Przybilla B; Kaudewitz P; Bieber K
Hautarzt; 1989; 40 Suppl 9():54-7. PubMed ID: 2681078
[TBL] [Abstract][Full Text] [Related]
10. Electron microscopy of the effects of dithranol on healthy and on psoriatic skin.
Kanerva L
Am J Dermatopathol; 1990 Feb; 12(1):51-62. PubMed ID: 2316816
[TBL] [Abstract][Full Text] [Related]
11. [Effect of the treatment of psoriasis with dithranol in comparison with a combination of dithranol and a corticosteroid].
Gloor M; Graf R; Wirth H; Landau M
Hautarzt; 1983 Oct; 34(10):500-3. PubMed ID: 6643055
[TBL] [Abstract][Full Text] [Related]
12. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
[TBL] [Abstract][Full Text] [Related]
13. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
[TBL] [Abstract][Full Text] [Related]
14. [Effect of dithranol therapy on membrane, basement membrane and nuclear markers in psoriasis lesions].
Wollina U; Schlesier F; Schaarschmidt H; Knopf B; Hipler C; Henkel U; Roth H; Bartá U
Z Hautkr; 1987 Feb; 62(4):313-8. PubMed ID: 3554801
[TBL] [Abstract][Full Text] [Related]
15. Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid.
Swinkels OQ; Prins M; Kucharekova M; de Boo T; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
Br J Dermatol; 2002 Apr; 146(4):621-6. PubMed ID: 11966693
[TBL] [Abstract][Full Text] [Related]
16. "Ditrawash"--a novel remover of dithranol (anthralin) for short contact therapy of psoriasis.
Mustakallio KK
Acta Derm Venereol Suppl (Stockh); 1989; 146():201-2. PubMed ID: 2609870
[TBL] [Abstract][Full Text] [Related]
17. Mast cell alterations in chronic psoriasis vulgaris: response to low-strength anthralin treatment. A transmission electron microscopic study.
Brody I
Ups J Med Sci; 1986; 91(1):1-16. PubMed ID: 3716018
[TBL] [Abstract][Full Text] [Related]
18. Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol).
Remitz A
Acta Derm Venereol; 1989; 69(4):351-4. PubMed ID: 2568062
[TBL] [Abstract][Full Text] [Related]
19. Measurement of plaque thickness and evaporative water loss in psoriasis with PUVA and dithranol treatment.
Rogers S
Clin Exp Dermatol; 1993 Jan; 18(1):21-4. PubMed ID: 8440047
[TBL] [Abstract][Full Text] [Related]
20. The systemic effect of dithranol treatment in psoriasis.
Goodfield MJ; Hull SM; Cunliffe WJ
Acta Derm Venereol; 1994 Jul; 74(4):295-7. PubMed ID: 7976091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
